This is a preview of subscription content, log in via an institution to check access.
Notes
incremental cost-effectiveness ratios
Reference
Ouattara E, et al. Clinical Impact and Cost-effectiveness of Making 3rd-Line ART Available in Sub-Saharan Africa: A Model-based Analysis in Cote d' Ivoire. 20th Conference on Retroviruses and Opportunistic Infections : abstr. 1115, 3 Mar 2013.
Rights and permissions
About this article
Cite this article
Third-line antiretroviral therapy cost effective in Côte d'Ivoire?. PharmacoEcon Outcomes News 676, 10 (2013). https://doi.org/10.1007/s40274-013-0333-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0333-6